What companies are GLENMARK.BO's competitors?

Glenmark Pharmaceuticals Limited (GLENMARK.BO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GLENMARK.BO compare to its peers?

The peer comparison table on this page shows Glenmark Pharmaceuticals Limited (GLENMARK.BO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GLENMARK.BO operate in?

Glenmark Pharmaceuticals Limited (GLENMARK.BO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GLENMARK.BO

Glenmark Pharmaceuticals Limited

BSE·Drug Manufacturers, Specialty & Generic · Healthcare

₹2,198.20₹43.70−1.95%

Market cap₹620.39B·Market closed·Jul 22 9:59 AM UTC

Frequently Asked Questions About GLENMARK.BO

What companies are GLENMARK.BO's competitors?: Glenmark Pharmaceuticals Limited (GLENMARK.BO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GLENMARK.BO compare to its peers?: The peer comparison table on this page shows Glenmark Pharmaceuticals Limited (GLENMARK.BO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GLENMARK.BO operate in?: Glenmark Pharmaceuticals Limited (GLENMARK.BO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GLENMARK.BO

Glenmark Pharmaceuticals Limited

BSE·Drug Manufacturers, Specialty & Generic · Healthcare

₹2,198.20₹43.70−1.95%

Market cap₹620.39B·Market closed·Jul 22 9:59 AM UTC

Peers


AUROPHARMA.NS	Aurobindo Pharma Limited	₹1,533.60	₹882.4B
AUROPHARMA.BO	Aurobindo Pharma Limited	₹1,532.95	₹880.6B
LAURUSLABS.BO	Laurus Labs Limited	₹1,577.65	₹852.5B
LAURUSLABS.NS	Laurus Labs Limited	₹1,577.80	₹852.4B
ALKEM.BO	Alkem Laboratories Limited	₹5,588.75	₹668.1B
ALKEM.NS	Alkem Laboratories Limited	₹5,585.00	₹667.8B
BIOCON.BO	Biocon Limited	₹437.95	₹598.6B
BIOCON.NS	Biocon Limited	₹437.95	₹598.3B
GLAXO.NS	GlaxoSmithKline Pharmaceuticals Limited	₹2,552.80	₹432.5B
GLAXO.BO	GlaxoSmithKline Pharmaceuticals Limited	₹2,551.10	₹432.4B

Frequently Asked Questions About GLENMARK.BO

What companies are GLENMARK.BO's competitors?: Glenmark Pharmaceuticals Limited (GLENMARK.BO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GLENMARK.BO compare to its peers?: The peer comparison table on this page shows Glenmark Pharmaceuticals Limited (GLENMARK.BO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GLENMARK.BO operate in?: Glenmark Pharmaceuticals Limited (GLENMARK.BO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.